Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Long

Adult Reconstructive Orthopaedic Surgery Los Angeles, CA Medical Doctor

NPI 1023067055 CMS profile 91401

1300 N Vermont Ave Ste 100, Los Angeles, CA 90027

Open in the dashboard

General payments

$2,838,551

133 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Long of Los Angeles, CA is reported in the CMS Open Payments database as having received $2,838,551 across 133 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,523 16
2024 General $2,537 8
2023 General $637,856 20
2022 General $582,337 22
2021 General $564,461 22
2020 General $512,081 23
2019 General $536,756 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Long
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Long were reported at $2,523. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year William Long Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $536,756 $1,416 $292–$9,336 $163
2020 $512,081 $647 $141–$6,474 $114
2021 $564,461 $1,073 $211–$6,497 $132
2022 $582,337 $1,217 $236–$6,299 $149
2023 $637,856 $1,082 $246–$6,818 $160
2024 $2,537 $1,575 $323–$8,944 $164
2025 $2,523 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $2,821,505 63 payments
  2. Total Joint Orthopedics, Inc. $11,173 21 payments
  3. Smith+Nephew, Inc. $4,313 29 payments
  4. Stryker Corporation $1,394 15 payments
  5. Advanced Orthopaedic Solutions, Inc. $103 1 payment
  6. Collegium Pharmaceutical, Inc. $32 2 payments
  7. Solventum Corporation $16 1 payment
  8. ConvaTec Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,823,877 71 payments
  2. Consulting Fee $8,375 9 payments
  3. Food and Beverage $3,540 44 payments
  4. Travel and Lodging $2,760 9 payments
Products named General payments · program years 2019–2025
  1. G7 Hips $1,041,977 24 payments
  2. G7 Hips $685,247 13 payments
  3. G7 Hips $562,591 12 payments
  4. G7 Hips $443,139 9 payments
  5. OSS Orthopedic Salvage System $87,735 1 payment
  6. REAL INTELLIGENCE $2,149 11 payments
  7. NAVIO $1,141 7 payments
  8. MAKO $1,005 10 payments
  9. RI Hip Navigation $950 4 payments
  10. JOURNEY II $950 4 payments
  11. Other $3,628 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

28

Median for Orthopedic Surgery: 203

Drug cost

$74

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tramadol Hcl Generic 17 $67
Amoxicillin Generic 11 $7

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$122,900

Medicare's payments for the services billed

Medicare patients

230

Average age 74

Services billed

422

166 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 47%
Ischemic heart disease 38%
Chronic kidney disease 30%
Heart failure 26%
COPD 25%
Depression 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record